Company news
Cardax Inc (OTC:CDXI) news
Cardax Inc news releases on 6ix. Latest, Aug 31, 2021: Cardax Refocuses on ZanthoSyn® Consumer Health Business
Press releases & updates
Cardax Refocuses on ZanthoSyn® Consumer Health Business
August 31, 2021
Cardax Voluntarily Suspends SEC Reporting Obligations
August 11, 2021
Cardax Reports Q1 2021 Results
May 14, 2021
Cardax Reports 2020 Results
April 15, 2021
Cardax Reports Q3 2020 Results
November 13, 2020
Cardax Reports Q2 2020 Results
August 17, 2020
Cardax Reports Q1 2020 Results
May 15, 2020
Cardax Reports 2019 Annual Results
March 30, 2020
Cardax Releases White Paper on the Potential Role of Astaxanthin in the Treatment of Coronavirus Disease
March 20, 2020
Cardax, Inc. Announces Reverse Stock Split of Common Stock
January 14, 2020
Cardax Reports Q3 2019 Results
November 14, 2019
Cardax Announces Interim Results from CHASE Clinical Trial
September 23, 2019
Cardax Reports Q2 2019 Results
August 14, 2019
Cardax Files Registration Statement for Proposed $15 Million Follow-On Offering
August 14, 2019
Cardax Reports Q1 2019 Results
May 17, 2019
Cardax Reports 2018 Results
March 28, 2019
Cardax to Present at NobleCon XV
January 25, 2019
Cardax and GNC Announce Expanded ZanthoSyn® Sales and Marketing Program
December 3, 2018
Cardax Names Former Amarin Head of Development Paresh N. Soni, MD, PhD, to lead Clinical and Regulatory Strategy
November 28, 2018
Cardax Reports Q3 2018 Results
November 13, 2018
Cardax Launches Human Clinical Trial Targeting Cardiovascular Inflammatory Health
October 2, 2018
Cardax Reports Q2 2018 Results
August 13, 2018
Cardax Announces Successful Completion of Warrant Exchange Offer
July 30, 2018
Cardax Announces Extension of Warrant Exchange Offer to July 27, 2018
July 23, 2018
Cardax Announces Effectiveness of Registration Statement and Commencement of Warrant Exchange Offer
June 22, 2018
Cardax Engages Industry Veteran Fred Sancilio, Ph.D., to Launch Orphan Drug Development Program
June 13, 2018
Cardax Adds Makarand Jawadekar, Ph.D., and Elona Kogan to its Board of Directors
June 1, 2018
Cardax Reports Q1 2018 Results
May 9, 2018
Cardax Announces Warrant Exchange Offer
May 2, 2018
Cardax Reports 2017 Results
March 27, 2018
Cardax Inks Deal to Distribute ZanthoSyn® in China
February 17, 2018
Cardax's ZanthoSyn® is No. 1 Seller at GNC Hawaii Stores
February 17, 2018
Cardax Hires Gilbert Shin as VP, Retail Sales and Marketing
December 7, 2017
ZanthoSyn® from Cardax Now Available at 3,000+ GNC Corporate Stores in the U.S.
December 7, 2017
Cardax Refutes Allegations by Competitive Trade Group, NAXA
December 5, 2017
Cardax Reports Q3 2017 Results
November 14, 2017
Cardax to Lead Plenary Session at Regenerative Medicine Conference
November 6, 2017
Cardax and GNC Sign Mutual Exclusivity Agreement for ZanthoSyn®
October 20, 2017
Cardax Welcomes Cardiovascular Research Breakthrough
September 19, 2017
Cardax Promotes David M. Watumull to COO; Partially Restores Compensation Company-Wide
September 7, 2017
Cardax Attracts $2.75M in Investment
August 28, 2017
Cardax Reports Q2 2017 Results
August 11, 2017
ZanthoSyn Going National with GNC
August 10, 2017
ZanthoSyn Now Available on GNC.com
June 27, 2017
Cardax Astaxanthin Compound Chosen for Important NIH Anti-Aging Research Program
June 18, 2017
Cardax Q1 2017 Revenues Triple vs. Prior Two Quarters Combined
May 15, 2017
Cardax Astaxanthin Compound CDX-085 Stimulates Anti-Aging Gene in Mice
March 28, 2017
Cardax Secures Access to Funds Under Equity Purchase Agreement
February 9, 2017
Cardax Takes Important Step to Access Funds Under Equity Purchase Agreement
February 8, 2017
Cardax Announces Launch of ZanthoSyn™ in Hawaii GNC Stores
January 25, 2017